A community for China's biotech and pharmaceutical industries.

The biotech and pharmaceutical industries are taking priority in China. Recent changes to safety regulations and a general reorganization have increased BioChina’s productivity and influence in the life sciences. With a large scientific community, BioChina has appealed to foreign biotech companies, which now have a strong presence within the country and in the global market. China’s strong economy and dedication to the life sciences is expected to contribute to a thriving biotech industry now and in the future.

Sponsor
Pfizer


Hotbed News
Two Biopharma Female Execs Pen Open Letter Opposing Firms that Hire Models for Industry Parties Monday, February 08, 2016
WuXi AppTec Congratulates MSD On Receiving FDA Approval Of ZEPATIER Wednesday, February 03, 2016
Exec Shares Tips: Most Common Job Seeking Mistakes to Avoid Wednesday, January 27, 2016
BeiGene Plans $127 Million U.S. IPO In February Thursday, January 21, 2016
Biotech 2016: Now Starts the Hangover Friday, January 29, 2016
China Considers Revising Biotech Regulations Monday, January 11, 2016
Rise Above Your Need for Control Monday, January 18, 2016
Social Media Mistakes that Could Cost You the Job Monday, January 18, 2016
Simcere To Stage $1 Billion Hong Kong IPO Friday, January 08, 2016
Jiangsu Hansoh Pharma Now Said To Plan $3 Billion IPO Thursday, January 07, 2016
12345678910